We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Relay Therapeutics Inc (NASDAQ:RLAY) stands against the other medical AI stocks.

Barclays (LON:BARC) initiated coverage on Natera shares (NASDAQ:NTRA), currently trading at $171.93, with an Overweight rating and a $200 price target. The stock has demonstrated remarkable momentum,

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other AI stocks. Insights on AI’s Potential and Its Evolving Capabilities AI is rapidly advancing,

Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating and setting a price target of $70.

Barclays (LON:BARC) adjusted the firm's stance on Netflix (NASDAQ:NFLX) stock, upgrading it from Underweight to Equalweight with a new price target of $900, a significant increase from the previous $715.

We recently compiled a list of the 10 AI News You Probably Missed. In this article, we are going to take a look at where Lumentum Holdings Inc. (NASDAQ:LITE) stands against the other AI stocks. AI Boosts Data Center Market to New Heights According to Synergy Research Group,

Barclays (LON:BARC) began coverage on Guardant Health (NASDAQ:GH) shares, assigning an Overweight rating and setting a price target of $60. The new outlook comes as Guardant Health, a precision oncology company,

Barclays (LON:BARC) reaffirmed its positive stance on Replimune Group (NASDAQ:REPL), maintaining an Overweight rating and a $17.00 price target, representing significant upside from the current price of $11.

Barclays (LON:BARC) analyst Nicholas Campanella revised the price target for Edison International (NYSE:EIX) shares, reducing it to $67.00 from the previous $76.00, while maintaining an Overweight rating on the company's stock.

The Nasdaq led gains among Wall Street's main indexes on Wednesday, as investors cheered streaming giant Netflix's strong quarterly performance and President Donald Trump's multi-billion dollar support to bolster AI infrastructure.

Marvell Technology (NASDAQ:MRVL) and Nvidia (NASDAQ:NVDA) arise as leaders in artificial intelligence semiconductor firms in 2025, according to an extensive outlook by Barclays. Broadcom (NASDAQ:AVGO),

Barclays upgraded Lumentum Holdings Inc (NASDAQ:LITE) to "Overweight" from "Underweight," setting a price target of $125, given significant growth potential driven by surging demand from hyperscale customers.